Ligand Pharmaceuticals LGND
NASDAQ LGND
$302.96 +0.22 (+0.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Cost of Revenue (2011 - 2019)

Updated

Ligand Pharmaceuticals' Cost of Revenue was $3.15 million in Q3 2019, up 115.5% from $1.46 million a year earlier and up 30.9% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Cost of Revenue (2011 - 2019) Analysis & Trends

On a trailing twelve-month basis, Ligand Pharmaceuticals' Cost of Revenue was $12.37 million through Sep 30, 2019, up 141.5% year-over-year; for FY2018, it came in at $6.34 million, up 18.1% from FY2017.

  • Cost of Revenue shows a five-year compound annual growth rate of 2.0% (FY2013 to FY2018).
  • In earlier years, Cost of Revenue was $5.37 million in FY2017 (-3.7%), $5.57 million in FY2016 (-4.1%), $5.81 million in FY2015 (-36.4%) and $9.14 million in FY2014 (+59.4%).
  • Quarterly Cost of Revenue has moved between $341,000 (Q1 2017) and $4 million (Q4 2014) over five years.
  • Compared with a year earlier, Cost of Revenue has increased for four straight quarters, with growth averaging 95.6% over the last eight quarters.
  • The best year-over-year quarter for Cost of Revenue over five years was Q1 2019 (growth of 389.6%); the worst was Q4 2015 (a decline of 77.9%).
  • Per Business Quant data, LGND's Cost of Revenue in the three quarters before Q3 2019 was $2.41 million (Q2 2019), $3.86 million (Q1 2019) and $2.96 million (Q4 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Ligand Pharmaceuticals 6.03 Bn 2.50 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 3.15 Mn
Jun 30, 2019 2.41 Mn
Mar 31, 2019 3.86 Mn
Dec 31, 2018 2.96 Mn
Sep 30, 2018 1.46 Mn
Jun 30, 2018 1.13 Mn
Mar 31, 2018 788,000.00
Dec 31, 2017 1.74 Mn
Sep 30, 2017 2.39 Mn
Jun 30, 2017 903,000.00
Mar 31, 2017 341,000.00
Dec 31, 2016 2.90 Mn
Sep 30, 2016 999,000.00
Jun 30, 2016 720,000.00
Mar 31, 2016 955,000.00
Dec 31, 2015 884,000.00
Sep 30, 2015 1.25 Mn
Jun 30, 2015 2.60 Mn
Mar 31, 2015 1.07 Mn
Dec 31, 2014 4.00 Mn
API Access

Ligand Pharmaceuticals Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=LGND&period=max&api_key=YOUR_API_KEY